Do most people keep weight off after stopping GLP-1 drugs?

What's this video probably claiming?

Based on the caption, @laurenhughes418 is pushing back on the widely circulated narrative that stopping GLP-1 medications like semaglutide or tirzepatide guarantees rapid, total weight regain. She's citing what sounds like a large real-world dataset, approximately 8,000 patients, to argue that weight stability after discontinuation is more common than the doom-and-gloom headlines suggest. The framing, calling regain "the biggest myth," positions her as a myth-buster, which is a popular content format in the GLP-1 TikTok space right now. Given the hashtags referencing Mounjaro UK and the GLP-1 community, she's likely speaking to people who are either on these medications or considering stopping them. Without the transcript, we can't confirm what she means by "stable" or how long she claims that stability lasts, but the caption specifically says "over 1 year," which is a testable, specific claim worth scrutinizing carefully.

What does the science actually show?

The evidence on post-discontinuation weight trajectories is genuinely more complicated than either side admits. The STEP 4 trial (Wilding et al., 2022, NEJM) followed participants who stopped semaglutide 2.4mg after 20 weeks and found they regained roughly two-thirds of their lost weight within 12 months. That's the study behind the "everyone gains it back" narrative, and it's real. However, a 2024 observational analysis using US insurance claims data published in Obesity (Ghusn et al., 2024) found more heterogeneous outcomes, with a meaningful subset of patients maintaining significant weight loss beyond 12 months post-discontinuation, particularly those who had made concurrent lifestyle changes. The clinical picture isn't uniform. Duration of treatment, degree of initial loss, metabolic health baseline, and behavioral factors all appear to influence what happens after stopping. The "most people stay stable" framing likely overstates what the observational data can actually confirm.

Where does the social media noise diverge from clinical reality?

Here's where this video is likely doing its audience a disservice, even if unintentionally. Real-world observational studies are not clinical trials. When someone says "8,000 real patients" stayed stable, that sounds more rigorous than it is. Observational data is subject to selection bias: people who successfully maintained weight after stopping are more likely to have continued engaging with healthcare systems, generating the data in the first place. People who regained rapidly and dropped out of care are systematically underrepresented. Second, "stable for over 1 year" needs a definition. Does that mean within 5% of their lowest weight? 10%? Back to their pre-treatment weight? These distinctions matter enormously for someone deciding whether to stop medication. The GLP-1 TikTok community tends to flatten these nuances into reassuring soundbites, and while combating unnecessary panic is reasonable, swinging to "most people are fine" without caveats is its own form of misinformation.

What should you actually know?

The honest answer is that post-discontinuation outcomes vary significantly by individual, and no single study, real-world or otherwise, has definitively resolved this question for the general population using these drugs. What the clinical evidence does consistently show is that GLP-1 receptor agonists work partly by suppressing appetite through mechanisms that reverse when the drug clears your system. For most people, that biological pressure to regain exists. Whether lifestyle changes, metabolic improvements, or other factors override that pressure differs person to person. A 2023 review in Nature Medicine (Batterham, 2023) described GLP-1-mediated weight loss as requiring ongoing pharmacological support for sustained effect in the majority of patients. That's not a reason to panic, but it is a reason to have an honest conversation with a clinician before stopping, rather than taking reassurance from a 60-second TikTok as your primary information source.